Endo encouraged on US pricing condition

Endo “continues to be encouraged” that downward pricing pressures the company has experienced in the US generic retail market “over the past few years appear to be stabilising”, president and chief executive officer Paul Campanelli has said.

Endo “continues to be encouraged” that downward pricing pressures the company has experienced in the US generic retail market “over the past few years appear to be stabilising”, president and chief executive officer Paul Campanelli has said.

“We’ve seen promising early signals and remain cautiously optimistic,” he told investors as Endo presented second quarter results, echoing previous...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business